Henan Hengxing Science & Technology Co EBITDA per Employee
The EBITDA per Employee of Henan Hengxing Science & Technology Co (002132.SZ) as of Oct 14, 2026 is 35,907.74 CNY. In the previous year, EBITDA per Employee was 13,695.81 CNY — a change of 162.18% (higher).
Get this data via API
Financial Data API
EBITDA per Employee
35,907.74CNY
YoY
162.18%
Last updated:
The Henan Hengxing Science & Technology Co EBITDA per Employee history
3 Years
10 Years
25 Years
Max
| YEAR | EBITDA per Employee | YoY |
|---|---|---|
| 35,907.74CNY | +162.18% | |
| 13,695.81CNY | -59.37% | |
| 33,709.26CNY | -43.34% | |
| 59,495.39CNY | +54.92% | |
| 38,404.80CNY | -18.62% | |
| 47,190.38CNY | +86.11% | |
| 25,356.02CNY | -198.58% | |
| -25,721.08CNY | -204.01% | |
| 24,729.25CNY | -31.78% | |
| 36,248.63CNY | +389.32% | |
| 7,407.95CNY | +23.25% | |
| 6,010.27CNY | — |
Henan Hengxing Science & Technology Co Stock analysis
Frequently Asked Questions about Henan Hengxing Science & Technology Co stock
EBITDA per Employee of Henan Hengxing Science & Technology Co is 35,907.74 CNY in 2025.
EBITDA per Employee of Henan Hengxing Science & Technology Co changed from 13,695.81 CNY to 35,907.74 CNY, representing a 162.18% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of EBITDA per Employee Henan Hengxing Science & Technology Co since 2006 – with annual values, charts, and detailed analysis.
EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.
EBITDA per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Henan Hengxing Science & Technology Co historically and in real time.
Workforce — Henan Hengxing Science & Technology Co
All Key Metrics — Henan Hengxing Science & Technology Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth